Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luping Zhao

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Gynecologic Oncology|October 8, 2011
Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancerAlan N Gordon, Michael Teneriello, Mike F Janicek, et al.
Cancer Research|June 11, 2020
The Lymphatic Cell Environment Promotes Kaposi Sarcoma Development by Prox1-Enhanced Productive Lytic Replication of Kaposi Sarcoma Herpes VirusDongwon Choi, Eunkyung Park, Kyu Eui Kim, et al.
Investigational New Drugs|August 29, 2009
Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: results of a phase II, randomized, noncomparative studyDonald A Richards, Paul R Kuefler, Carlos Becerra, et al.
Cancer|August 3, 2025
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b studyMohammed M Milhem, Yousef Zakharia, Diwakar Davar, et al.
JCI Insight|July 10, 2020
Organogenesis and distribution of the ocular lymphatic vessels in the anterior eyeYifan Wu, Young Jin Seong, Kin Li, et al.
Circulation Research|June 15, 2022
Piezo1-Regulated Mechanotransduction Controls Flow-Activated Lymphatic ExpansionDongwon Choi, Eunkyung Park, Roy P Yu, et al.
JAMA Oncology|April 10, 2020
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical TrialNaiyer A Rizvi, Byoung Chul Cho, Niels Reinmuth, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Gynecologic Oncology|October 8, 2011
Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancerAlan N Gordon, Michael Teneriello, Mike F Janicek, et al.
Cancer Research|June 11, 2020
The Lymphatic Cell Environment Promotes Kaposi Sarcoma Development by Prox1-Enhanced Productive Lytic Replication of Kaposi Sarcoma Herpes VirusDongwon Choi, Eunkyung Park, Kyu Eui Kim, et al.
Investigational New Drugs|August 29, 2009
Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: results of a phase II, randomized, noncomparative studyDonald A Richards, Paul R Kuefler, Carlos Becerra, et al.
Cancer|August 3, 2025
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b studyMohammed M Milhem, Yousef Zakharia, Diwakar Davar, et al.
JCI Insight|July 10, 2020
Organogenesis and distribution of the ocular lymphatic vessels in the anterior eyeYifan Wu, Young Jin Seong, Kin Li, et al.
Circulation Research|June 15, 2022
Piezo1-Regulated Mechanotransduction Controls Flow-Activated Lymphatic ExpansionDongwon Choi, Eunkyung Park, Roy P Yu, et al.
JAMA Oncology|April 10, 2020
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical TrialNaiyer A Rizvi, Byoung Chul Cho, Niels Reinmuth, et al.
Pageof 7